F. X. Dillon, “Anesthesia Issues in the Perioperative Management of Myas-Thenia Gravis,” Seminars in Neurology, Vol. 24, No. 1, 2004, pp. 83-94. doi:10.1055/s-2004-829587

has been cited by the following article:

• TITLE: Successful Use of Sugammadex in a Myasthenic Patient Case Report

  AUTHORS: Silvia Kangassu Rios, Daiana Gomes, Marcos Lopes De Miranda, Carlos Frederico La Cava, Carlos Darcy Bersot

  KEYWORDS: Sugammadex; Myasthenia Gravis; Rocuronium; Neuromuscular Monitoring; Anesthesia

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.3 No.1, January 31, 2013

  ABSTRACT: The Myasthenia gravis (MG) is an autoimmune disease that affects neuromuscular transmission and leads to a large variation of sensibility on depolarizing and nondepolarizing neuromuscular blocking drugs. Sugammadex is a new drug with the capability to successfully revert the nondepolarizing neuromuscular blocking. This case report will show a patient with MG that was scheduled for thymectomy, with the objective to use sugammadex to reverse a rocuronium induced deep level of neuromuscular block and observing the safe use of sugammadex without complications.